October 30, 2017 / 8:48 PM / 2 months ago

BRIEF-PDL Biopharma issues response to Neos Therapeutics rejection of PDL acquisition proposal

Oct 30 (Reuters) - Pdl Biopharma Inc

* PDL Biopharma issues statement in response to Neos Therapeutics rejection of PDL acquisition proposal

* PDL Biopharma Inc - ‍PDL’s proposal to Neos remains outstanding through November 8, 2017 & co will evaluate “all of its options” in interim​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below